Cannabis Use Disorder Market is segmented By Treatment (Pharmacotherapy (Synthetic cannabinoids, CB1 receptor antagonists, Antidepressants, Other medications), Behavioral Therapies (Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), Contingency Management (CM))), By Route of Administration (Oral, Transdermal, Inhalation, Sublingual), By End User (Hospitals, Specialty Clinics, Rehabilitation Centers, Homecare Settings), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned.